RxDoctor Payments Data

David Kellen, MD

Family Medicine · Gulf Breeze, FLNPI 1396889671

Payments from drug & device makers

$2,555in general payments, 2019–2025

Across 138 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$450
  • Amgen$306
  • GSK$298
  • AbbVie$256
  • Pfizer$222
  • Novo Nordisk$161
  • plus $862 from 21 others

What the payments were for

  • Food & beverage$2,25788%
  • Education$29812%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,555 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$70,872
Medicare patients
295
Services billed
1,057

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide52$67,550
FarxigaDapagliflozin Propanediol47$51,658
EliquisApixaban12$16,073
JardianceEmpagliflozin18$13,855
MounjaroTirzepatide14$13,666
TrulicityDulaglutide11$10,010
JanuviaSitagliptin Phosphate11$6,343
Atorvastatin Calcium468$6,317
BelsomraSuvorexant12$5,028
Losartan Potassium335$4,232
Levothyroxine Sodium230$2,806
Omeprazole191$2,603
Rosuvastatin Calcium153$2,499
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide140$2,382
Arnuity ElliptaFluticasone Furoate11$2,207

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$161$67,55052 claims
AstraZenecaFarxiga$111$51,65847 claims
Lilly USA, LLCMounjaro, Trulicity$137$23,67625 claims
PfizerEliquis, Paxlovid$222$17,50332 claims
Boehringer IngelheimJardiance$67$13,85518 claims
GSKArnuity Ellipta$298$2,20711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Gulf Breeze

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →